Twitter | Pretraživanje | |
Genialis
Genialis builds in silico models of disease biology to advance discovery & de-risk development of novel therapeutics.
498
Tweetovi
277
Pratim
424
Osobe koje vas prate
Tweetovi
Genialis 30. sij
ICYMI, the latest episode of , discusses with , empowering scientists on the front lines of curing cancer.
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
DDNews Online 22. sij
Reply Retweet Označi sa "sviđa mi se"
Genialis 22. sij
We’re joining our Expressions software platform and analytics IP with Oncologie’s clinical and translational expertise to refine patient stratification methodologies.
Reply Retweet Označi sa "sviđa mi se"
Genialis 20. sij
Our CEO will be talking about divining predictive signatures in with at on Jan 22 at 1 pm. About the talk: We’re excited to join and other 2500+ attendees! Let us know if you are around.
Reply Retweet Označi sa "sviđa mi se"
Genialis 15. sij
Odgovor korisniku/ci @mitcnc
Reply Retweet Označi sa "sviđa mi se"
Genialis 15. sij
We will be among a stellar group of companies tonight at the MIT club of NorCal in healthcare event. Drop by and see us and meet all the others too!
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
Rafael Rosengarten 15. sij
The whole event was a ton of fun. Lots of diverse experience on the panel!
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
EBD Group 14. sij
Reply Retweet Označi sa "sviđa mi se"
Genialis 12. sij
Just arriving at ? Don’t miss the Digital Medicine and Medtech Showcase discussion on “The Impact of AI: How AI and ML are transforming R&D, and what's next to come.” Save your seat:
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
EBD Group 6. sij
Open to the public on Jan 13, this discussion will highlight how and is being used. Come hear at RSVP >>
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
Rafael Rosengarten 9. sij
Check out latest podcast, with Charlie and his right-hand data man, Nigel Beard, discussing how their platform for measuring genotype and phenotype at single cell resolution is revolutionizing our efforts to
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
Rafael Rosengarten 9. sij
Yesterday declared single cell multimodal omics the method of the year for 2019. Well hold on to your hats, because of says you ain’t seen nothing yet!
Reply Retweet Označi sa "sviđa mi se"
Genialis 9. sij
is the single cell analysis platform company empowering researchers to . Join CEO & CTO Nigel Beard, with our own , discussing the future of , , & .
Reply Retweet Označi sa "sviđa mi se"
Genialis 8. sij
2019 laid the foundation. 2020 is all about enabling our partners to get breakthrough drugs to patients with the most urgent need. Read more:
Reply Retweet Označi sa "sviđa mi se"
Genialis 7. sij
Odgovor korisniku/ci @Genialis
Digital Medicine and Medtech Showcase Monday, January 13, 4:00 – 5:00 pm Parc 55 San Francisco, Level 4, Cyril Magnin Ballroom I II & III The Impact of AI: How AI and ML are transforming R&D, and what's next to come
Reply Retweet Označi sa "sviđa mi se"
Genialis 7. sij
Odgovor korisniku/ci @ron_alfa @RecursionPharma i 4 ostali
Come join the conversation with ; Anastasia Christianson ; ; Oodaye Shukla
Reply Retweet Označi sa "sviđa mi se"
Genialis 7. sij
Our CEO will be speaking on an allstar panel at the Digital Medicine and Medtech Showcase at JPM to discuss “The Impact of AI: How AI and ML are transforming R&D, and what's next to come.”
Reply Retweet Označi sa "sviđa mi se"
Genialis proslijedio/la je tweet
EBD Group 1. sij
Open to the public on Jan 13, this discussion will highlight how and is being used. Come hear at RSVP >>
Reply Retweet Označi sa "sviđa mi se"
Genialis 20. pro
Happy holidays and a joyous New Year!
Reply Retweet Označi sa "sviđa mi se"
Genialis 19. pro
Odgovor korisniku/ci @Genialis
For more information or to register to attend,
Reply Retweet Označi sa "sviđa mi se"